| CIMCX | RAPCX | CIMCX / RAPCX | |
| Total Expense Ratio | 1.35 | 1.81 | 75% |
| Annual Report Gross Expense Ratio | 1.35 | 1.91 | 71% |
| Fund Existence | 24 years | 14 years | - |
| Gain YTD | 6.484 | 10.739 | 60% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 145B | 1.91B | 7,608% |
| Annual Yield % from dividends | 2.73 | 4.95 | 55% |
| Returns for 1 year | 5.96 | 18.15 | 33% |
| Returns for 3 years | 30.81 | 35.65 | 86% |
| Returns for 5 years | 21.70 | 36.70 | 59% |
| Returns for 10 years | 63.12 | 72.81 | 87% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NBIZ | 9.92 | 0.73 | +7.94% |
| Tradr 2X Short Nbis Daily ETF | |||
| EQRR | 80.77 | N/A | N/A |
| ProShares Equities for Rising Rates ETF | |||
| CPSU | 27.68 | -0.02 | -0.05% |
| Calamos S&P 500 Structured Alt Protection ETF - June | |||
| WTMF | 40.89 | -0.16 | -0.39% |
| WisdomTree Managed Futures Strategy ETF | |||
| IHE | 99.99 | -0.52 | -0.52% |
| iShares US Pharmaceuticals ETF | |||